Sacubitril/valsartan
CAS 936623-90-4 10 FDA-DMF suppliersSmall Molecule
Overview
Sacubitril/Valsartan is a combination of sacubitril, a neprilysin inhibitor, and valsartan, an angiotensin II receptor blocker, used to reduce the risk of cardiovascular death and hospitalization for heart failure patients with reduced ejection fraction. This combination enhances the protective neurohormonal systems of the heart while suppressing the harmful systems, promoting vasodilation and blood pressure reduction.
API suppliers (2)
Suppliers of Sacubitril/valsartan backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- HUHTAMAKI OY LEIRAS PHARMACEUTICALS
- VAMSI LABS LTDIndia
Chemical identity
- IUPAC name
- hexasodium;bis(4-[[(2S,4R)-5-ethoxy-4-methyl-5-oxo-1-(4-phenylphenyl)pentan-2-yl]amino]-4-oxobutanoate);bis((2S)-3-methyl-2-[pentanoyl-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]amino]butanoate);pentahydrate
- Canonical SMILES
- CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NN=N[N-]3)[C@@H](C(C)C)C(=O)[O-].CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NN=N[N-]3)[C@@H](C(C)C)C(=O)[O-].CCOC(=O)[C@H](C)C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)[O-].CCOC(=O)[C@H](C)C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)[O-].O.O.O.O.O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
- InChIKey
- ZASXKEGREHRXDL-CAWNUZPDSA-H
Therapeutic areas
Cardiovascular DiseasesHeart FailureHypertension
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.